A number of research firms have changed their ratings and price targets for AtriCure (NASDAQ: ATRC): 2/27/2023 – AtriCure was upgraded by analysts at StockNews.com from a 'sell' rating to a 'hold' rating. 2/22/2023 – AtriCure had its price target lowered by analysts at Canaccord Genuity Group Inc. from $81.00 to $74.00. They now have a 'buy' rating on the stock. 2/22/2023 – AtriCure had its price target lowered by analysts at BTIG Research from $65.00 to $55.00. They now have a 'buy' rating on the stock.

https://www.dailypolitical.com/2023/03/07/atricure-atrc-investment-analysts-recent-ratings-changes.html

#dailypolitical